New program helps formerly homeless quit smoking at home
NCT ID NCT04855357
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a voluntary program to help formerly homeless adults living in supportive housing make their homes smoke-free. Researchers provided one-on-one counseling to residents and trained staff to offer smoking cessation referrals. The trial involved 452 participants across 20 housing sites in the San Francisco Bay Area, aiming to reduce smoking and secondhand smoke exposure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (counseling and staff training)
What this could lead to
If successful, this could help formerly homeless adults voluntarily adopt smoke-free homes, reducing smoking rates and secondhand smoke exposure in supportive housing.
What could go wrong
This is a completed trial, but results may not apply to all housing settings. The intervention relies on voluntary participation, so some residents may not adopt smoke-free homes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States